Key facts
- It has raised $300.0M; the latest was Early Stage VC ($300.0M) in Apr 2026.
- Notable investors include Bain Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Beeline Medicines
- ·The full record, as it builds
Funding rounds
No funding rounds for Beeline Medicines are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Beeline Medicines
Provider of medical billing and revenue cycle management services designed to optimize financial operations for healthcare providers. The company offers end-to-end billing, coding, claims processing, and reimbursement management, supports compliance and analytics, and integrates with healthcare systems to improve accuracy and cash flow, enabling medical practices to streamline operations and maximize revenue performance.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2025
- Employees
- 40
- Website
- beelinemedicines.com/
- Ownership
- Privately Held (backing)
Beeline Medicines doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Beeline Medicines shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Beeline Medicines in its N-PORT filings yet. We sweep new filings monthly.